These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 15103320

  • 1. Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies.
    Rollman E, Hinkula J, Arteaga J, Zuber B, Kjerrström A, Liu M, Wahren B, Ljungberg K.
    Gene Ther; 2004 Jul; 11(14):1146-54. PubMed ID: 15103320
    [Abstract] [Full Text] [Related]

  • 2. Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery.
    Bråve A, Ljungberg K, Boberg A, Rollman E, Isaguliants M, Lundgren B, Blomberg P, Hinkula J, Wahren B.
    Mol Ther; 2005 Dec; 12(6):1197-205. PubMed ID: 16112909
    [Abstract] [Full Text] [Related]

  • 3. Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice.
    Shinoda K, Xin KQ, Jounai N, Kojima Y, Tamura Y, Okada E, Kawamoto S, Okuda K, Klinman D, Okuda K.
    Vaccine; 2004 Sep 09; 22(27-28):3676-90. PubMed ID: 15315847
    [Abstract] [Full Text] [Related]

  • 4. Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells.
    Hinkula J, Walther-Jallow L, Laurén A, Mäkitalo B, Oberg M, Wahren B, Fenyö EM, Spetz AL.
    Vaccine; 2009 Oct 30; 27(46):6424-31. PubMed ID: 19549607
    [Abstract] [Full Text] [Related]

  • 5. Immunogenicities of Env glycoproteins from circulating HIV-1 isolates in China focusing on the strategy of "DNA prime plus protein boost".
    Wang Z, Wang SX, Liu SY, Bao ZY, Zhuang DM, Li L, Zhang CH, Zhang L, Li JY, Lu S.
    Chin Med J (Engl); 2009 Oct 05; 122(19):2339-45. PubMed ID: 20079137
    [Abstract] [Full Text] [Related]

  • 6. Designed recombinant adenovirus type 5 vector induced envelope-specific CD8(+) cytotoxic T lymphocytes and cross-reactive neutralizing antibodies against human immunodeficiency virus type 1.
    Ura T, Yoshida A, Xin KQ, Yoshizaki S, Yashima S, Abe S, Mizuguchi H, Okuda K.
    J Gene Med; 2009 Feb 05; 11(2):139-49. PubMed ID: 19065543
    [Abstract] [Full Text] [Related]

  • 7. DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity.
    Buonaguro L, Devito C, Tornesello ML, Schröder U, Wahren B, Hinkula J, Buonaguro FM.
    Vaccine; 2007 Aug 10; 25(32):5968-77. PubMed ID: 17629365
    [Abstract] [Full Text] [Related]

  • 8. Effect of partial and complete variable loop deletions of the human immunodeficiency virus type 1 envelope glycoprotein on the breadth of gp160-specific immune responses.
    Gzyl J, Bolesta E, Wierzbicki A, Kmieciak D, Naito T, Honda M, Komuro K, Kaneko Y, Kozbor D.
    Virology; 2004 Jan 20; 318(2):493-506. PubMed ID: 14972518
    [Abstract] [Full Text] [Related]

  • 9. Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins.
    Mascola JR, Sambor A, Beaudry K, Santra S, Welcher B, Louder MK, Vancott TC, Huang Y, Chakrabarti BK, Kong WP, Yang ZY, Xu L, Montefiori DC, Nabel GJ, Letvin NL.
    J Virol; 2005 Jan 20; 79(2):771-9. PubMed ID: 15613305
    [Abstract] [Full Text] [Related]

  • 10. Combining DNA technologies and different modes of immunization for induction of humoral and cellular anti-HIV-1 immune responses.
    Bråve A, Hallengärd D, Malm M, Blazevic V, Rollman E, Stanescu I, Krohn K.
    Vaccine; 2009 Jan 07; 27(2):184-6. PubMed ID: 18992294
    [Abstract] [Full Text] [Related]

  • 11. DNA prime/protein boost immunization against HIV clade C: safety and immunogenicity in mice.
    Rasmussen RA, Ong H, Kittel C, Ruprecht CR, Ferrantelli F, Hu SL, Polacino P, McKenna J, Moon J, Travis B, Ruprecht RM.
    Vaccine; 2006 Mar 20; 24(13):2324-32. PubMed ID: 16406147
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of human immunodeficiency virus type 1 subtype C gag, pol, and gagpol DNA and alphavirus replicon vaccines.
    Megede JZ, Otten GR, Doe B, Liu H, Srivastava R, Greer C, Legg H, Tang T, Polo JM, Donnelly JJ, Ulmer JB, Barnett SW.
    Vaccine; 2006 Apr 05; 24(15):2755-63. PubMed ID: 16460840
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Maternal immune status influences HIV-specific immune responses in pups after DNA prime protein boost using mucosal adjuvant.
    Bråve A, Johansen K, Palma P, Benthin R, Hinkula J.
    Vaccine; 2008 Nov 05; 26(47):5957-66. PubMed ID: 18801400
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.
    Rollman E, Mathy N, Bråve A, Boberg A, Kjerrström A, van Wely C, Engström G, Johansson S, Aperia K, Eriksson LE, Benthin R, Ertl P, Heeney J, Hinkula J, Voss G, Wahren B.
    Vaccine; 2007 Mar 01; 25(11):2145-54. PubMed ID: 17254672
    [Abstract] [Full Text] [Related]

  • 16. 8 Br-cAMP enhances both humoral and cell-mediated immune responses induced by an HIV-1 DNA vaccine.
    Arai H, Xin KQ, Hamajima K, Lu Y, Watabe S, Takahashi T, Toda S, Okuda K, Kudoh I, Suzuki M, Okuda K.
    Gene Ther; 2000 Apr 01; 7(8):694-702. PubMed ID: 10800093
    [Abstract] [Full Text] [Related]

  • 17. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
    Bower JF, Green TD, Ross TM.
    Virology; 2004 Oct 25; 328(2):292-300. PubMed ID: 15464849
    [Abstract] [Full Text] [Related]

  • 18. Induction of HIV-1 subtype B and AE-specific neutralizing antibodies in mice and macaques with DNA prime and recombinant gp140 protein boost regimens.
    Center RJ, Wheatley AK, Campbell SM, Gaeguta AJ, Peut V, Alcantara S, Siebentritt C, Kent SJ, Purcell DF.
    Vaccine; 2009 Nov 05; 27(47):6605-12. PubMed ID: 19712773
    [Abstract] [Full Text] [Related]

  • 19. Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype.
    Pal R, Kalyanaraman VS, Nair BC, Whitney S, Keen T, Hocker L, Hudacik L, Rose N, Mboudjeka I, Shen S, Wu-Chou TH, Montefiori D, Mascola J, Markham P, Lu S.
    Virology; 2006 May 10; 348(2):341-53. PubMed ID: 16460776
    [Abstract] [Full Text] [Related]

  • 20. Reduced cellular immune responses following immunization with a multi-gene HIV-1 vaccine.
    Bråve A, Ljungberg K, Boberg A, Rollman E, Engström G, Hinkula J, Wahren B.
    Vaccine; 2006 May 22; 24(21):4524-6. PubMed ID: 16174543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.